No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
How Do Investors Really Feel About Haemonetics?
Vivasure Medical Announces European CE Mark Approval Of PerQseal Elite Vascular Closure System
Highland Arms Enterprises Acquires Camprendy
Express News | Haemonetics Corp : Citigroup Cuts Target Price to $71 From $72
An Intrinsic Calculation For Haemonetics Corporation (NYSE:HAE) Suggests It's 49% Undervalued
Haemonetics Corp. (HAE): Among the 10 Pro-Life Companies to Invest In Now?